MoonLake Immunotherapeutics
MLTX
#3397
Rank
โ‚ฌ3.17 B
Marketcap
50,33ย โ‚ฌ
Share price
0.56%
Change (1 day)
-5.48%
Change (1 year)

Revenue for MoonLake Immunotherapeutics (MLTX)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A a decrease over the revenue in the year 2022 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MoonLake Immunotherapeutics from 2022 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A
2022 N/A